BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Adebanjo TA, Pondo T, Yankey D, Hill HA, Gierke R, Apostol M, Barnes M, Petit S, Farley M, Harrison LH, Holtzman C, Baumbach J, Bennett N, McGuire S, Thomas A, Schaffner W, Beall B, Whitney CG, Pilishvili T. Pneumococcal Conjugate Vaccine Breakthrough Infections: 2001-2016. Pediatrics 2020;145:e20190836. [PMID: 32054822 DOI: 10.1542/peds.2019-0836] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Dunne EM, Pilishvili T, Adegbola RA. Assessing reduced-dose pneumococcal vaccine schedules in South Africa. Lancet Infect Dis 2020;20:1355-7. [PMID: 32857991 DOI: 10.1016/S1473-3099(20)30577-6] [Reference Citation Analysis]
2 Kanik-Yuksek S, Gülhan B, Özkaya-Parlakay A, Bedir Demirdağ T. Severe suppurative otitis media due to Streptococcus pneumoniae serotype 19A in a fully vaccinated infant by age. Hum Vaccin Immunother 2020;16:2779-80. [PMID: 32401687 DOI: 10.1080/21645515.2020.1747924] [Reference Citation Analysis]
3 Vyse A, Campling J, Czudek C, Ellsbury G, Mendes D, Reinert RR, Slack M. A review of current data to support decision making for introduction of next generation higher valency pneumococcal conjugate vaccination of immunocompetent older adults in the UK. Expert Rev Vaccines 2021;20:1311-25. [PMID: 34550850 DOI: 10.1080/14760584.2021.1984888] [Reference Citation Analysis]
4 Dion SB, Major M, Gabriela Grajales A, Nepal RM, Cane A, Gessner B, Vojicic J, Suaya JA. Invasive pneumococcal disease in Canada 2010-2017: The role of current and next-generation higher-valent pneumococcal conjugate vaccines. Vaccine 2021;39:3007-17. [PMID: 33824041 DOI: 10.1016/j.vaccine.2021.02.069] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Nasreen S, Wang J, Kwong JC, Crowcroft NS, Sadarangani M, Wilson SE, McGeer A, Kellner JD, Quach C, Morris SK, Sander B, Kus JV, Naus M, Hoang L, Rudzicz F, Fadel S, Marra F. Population-based incidence of invasive pneumococcal disease in children and adults in Ontario and British Columbia, 2002-2018: A Canadian Immunization Research Network (CIRN) study. Vaccine 2021;39:7545-53. [PMID: 34810001 DOI: 10.1016/j.vaccine.2021.11.032] [Reference Citation Analysis]
6 Mungall BA, Hoet B, Nieto Guevara J, Soumahoro L. A systematic review of invasive pneumococcal disease vaccine failures and breakthrough with higher-valency pneumococcal conjugate vaccines in children. Expert Rev Vaccines 2021. [PMID: 34882050 DOI: 10.1080/14760584.2022.2012455] [Reference Citation Analysis]